Warning letters sent by the Food and Drug Administration to 15 producers and sellers of CBD products show the agency is serious about enforcing current prohibitions on the marketing of goods containing cannabidiol, the non-psychoactive chemical contained in hemp.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.